Old Web
English
Sign In
Acemap
>
Paper
>
P-114A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma
P-114A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma
2015
Ahmed Kaseb
Humaid O. Al-Shamsi
J. Morris
Michiko Iwasaki
L. Xiao
Reham Abdel-Wahab
Kanwal Pratap Singh Raghav
Manal Hassan
Hesham M. Hassabo
Robert A. Wolff
Keywords:
Medicine
Bevacizumab
Erlotinib
Hepatocellular carcinoma
Second-line therapy
Phases of clinical research
Oncology
Internal medicine
second line treatment
Correction
Source
Cite
Save
Machine Reading By IdeaReader
24
References
0
Citations
NaN
KQI
[]